Study Design. Human lumbar anulus tissue and cultured human lumbar anulus cells were used in retrospective studies of the immunocytochemical localization of the vitamin D receptor (VDR) in disc tissue, and of the in vitro effects of the active metabolite of vitamin D, 1,25(OH) 2 D 3 , on anulus cell proliferation, cytokine, and proteoglycan (PG) production. 24,25-D 3 was also analyzed. Studies were approved by the authors' Human Subjects Institutional Review Board. Discs were obtained from surgical specimens and from control donors.
The vitamin D receptor (VDR), a member of the superfamily of steroid hormone receptors, acts to mediate the vitamin D endocrine system through binding of the active metabolite of vitamin D, 1,25-dihydroxyvitamin D (1,25(OH) 2 D 3 ), and then further acts by increasing or decreasing the transcription of target genes.
1 VDR expression has been documented in chondrocytes, macrophages, and synoviocytes. 2 In addition to the binding of 1,25(OH) 2 D 3 with the VDR, a second mechanism of action of 1,25(OH) 2 D 3 is now recognized. 1,25(OH) 2 D 3 is now known to induce rapid, nontranscriptional responses, which occur via activation of transmembrane signal transduction pathways, similar to the actions of cytokines and peptide hormones. 3 An expanding body of evidence supports the role of the vitamin D metabolites in chondrocyte proliferation and differentiation. Resting chondrocytes respond primarily to 24,25(OH)D and growth zone chondrocytes respond primarily to 1,25(OH) 2 D 3 . 4 -6 Klaus et al have shown that IGF-1 and 1,25(OH) 2 D 3 mutually upregulate their respective receptors in growth plate chondrocytes. 7 The effects on chondrocytes have been explored in the greatest depth by Schwartz et al in a series of studies, which have shown that the direct effects of TGF-␤ on chondrocytes are modulated by vitamin D metabolites in a cell maturation specific manner. 4 The No funds were received in support of this work. No benefits in any form have been or will be received from a commercial party related directly or indirectly to the subject of this manuscript.
vitamin D metabolites also regulate latent TGF-␤ incorporation into the ECM. 8 It is also now recognized that 1,25(OH) 2 D 3 has functions in tissues, which are not viewed as traditional targets of vitamin D action. 9 Examples include the parathyroid gland, 10, 11 skin, 12 thymus, 13 and ovarian cells. 14 Many organs, including gut, brain, heart, pancreas, kidneys, immune system, and skin, are now known to express the VDR. 15 Three recent studies evaluated patients with disc degeneration and produced evidence for intragenic polymorphisms in the VDR gene. 16 -18 Such studies provide clinical evidence that proper biologic interaction of disc cells with the vitamin D metabolites may be critical for disc health.
Not only is the disc exposed to vitamin D metabolites circulating in the plasma (which diffuses into the disc), but it simultaneously contacts 25-hydroxy vitamin D (25-OHD), 24,25-dihydroxyvitamin D 3 (24, 25 (OH)D 3 ), and 1,25(OH) 2 D 3 in the cerebrospinal fluid, which diffuses into the disc during motion and activity. 19 Structural changes in the extracellular matrix are an important component of disc degeneration. Matrix metalloproteinases (MMPs) are a family of enzymes that participate in this degradation. MMP-3 (stromelysin) degrades the collagenase-cleaved collagens and also degrades proteoglycans and fibronectin in the degenerating disc. 20 Recent work by Schmitz et al has shown that MMP-3 in the cartilage growth plate is regulated by the vitamin D metabolites via protein kinase C-dependent phosphorylation. 21 The vitamin D metabolites may play a similar role in degradation of the disc ECM.
In the present study, we ask whether cells of the human anulus express the VDR in vivo and in vitro, and then experimentally investigate the effect of in vitro administration of 1,25(OH) 2 D 3 on anulus cells cultured in monolayer or in a 3-dimensional microenvironment.
Materials and Methods

Tissue Source
Experimental study of disc specimens was approved prospectively by the authors' Human Subjects Institutional Review Board. Patient specimens were derived from surgical disc procedures performed on individuals with herniated discs and degenerative disc disease. Surgical specimens were transported to the laboratory (less than 30 minutes after surgical removal) in sterile tissue culture medium or placed in 10% neutral buffered formalin for histologic studies. Control specimens were obtained via the National Cancer Institute Cooperative Human Tissue Network; they were shipped overnight to the laboratory in sterile tissue culture medium, and then either processed for tissue culture or histology. Thompson Grade I discs (see below) were included to complete the immunohistochemical studies; due to early changes in the adult/teenager, these were obtained from children and young donors.
Study Populations
Specimens were graded using the Thompson scoring system 22 where Grade I describes a healthy disc with abundant proteoglycan and normal collagen lamellar structure; grades progress up to Grade V, which denotes a severely degenerated disc with prominent collagen lamellar bundles and decreased proteoglycan.
For the cytokine studies, anulus cells were obtained from lumbar discs of the following subjects based on disc Thompson For the immunocytochemical vitamin D receptor studies on paraffin-embedded disc tissue, demographic features and disc sites are listed in Table 1 .
For cell proliferation studies, anulus cells were derived from 5 Grade III discs from 3 subjects (a 50-year-old female, a 31-year-old male, and a 53-year-old female. All discs were lumbar sites). 
Culture of Anulus Cells in the
Vitamin D Receptor Immunocytochemical Detection
Specimens were fixed in 10% neutral buffered formalin and embedded in paraffin without decalcification. Slides were deparaffinized in xylene and hydrated through graded alcohols to distilled water (dH 2 O), sections incubated in 3% H 2 O 2 in methanol (Allegiance) for 5 minutes, and rinsed with dH 2 O and 2 rinses with 1% phosphate-buffered saline (PBS) (Boehringer-Mannheim). Sections were incubated with antivitamin D receptor (Affinity Bioreagents, Golden, CO) at 1:100 dilution overnight. Two percent normal rabbit serum with 0.25% Triton X-100 was used as a diluent and as the negative control incubation solution. Slides were rinsed 3 times in PBS, and incubated with biotinylated rabbit antirat secondary antibody (Vector Labs, Burlingame, CA) at a 1:50 dilution for 2 hours at room temperature. Slides were rinsed 3 times in PBS and incubated with peroxidase-conjugated streptavidin (Dako, Carpenteria, CA) for 20 minutes, rinses 3 times with PBS and incubated with Vector NovaRed chromagen (Vector Labs) for 5 minutes, rinsed with dH 2 O, counterstained with light green for 30 seconds, dehydrated, cleared, and mounted with a resinous mounting media.
Localization of the Vitamin D Receptor in Cultured Cells
For localization of the Vitamin D receptor in cultured cells, anulus cells were grown in monolayer culture (seeded at 150,000 cells/well) on a Lab-Tek Chamber Slide (Nunc, Napi-erville, IL) or in agarose as previously described. 25 Immunocytolocalization methods were carried out as described above. This study used cells from a surgical disc specimen from C 6 -7 of a 56-year-old male surgical patient.
Standardized Experimental Design for Cytokine Production by Anulus Cells in 3-Dimensional Culture
A paired experimental design was used to identify differences in cytokine production in conditioned media from control or 1,25(OH) 2 D 3 -treated cells, or in control or 24,25-D 3 -treated cells using ELISA assays described below.
Disc cells from the lumbar anulus were used immediately after initial culture and passage of cells to obtain sufficient cell numbers for experimental use as previously described. 25, 26 Sterile Gelfoam (Pharmacia & Upjohn Co., Kalamazoo, MI) sponges, an absorbable gelatin sponge prepared from purified porcine skins gelatin USP granules, was trimmed into 0.5 cm 3 cubes and used as the cell 3-dimensional growth microenvironment as previously described. [27] [28] [29] A cell suspension containing an average of 100,000 cells in Minimal Essential Medium with 20% fetal bovine serum (MEM20) was injected into each cube with a pipette. Replicate collagen sponges were placed on Costar Transwell Clear Inserts (Costar) in 24-well plates and soaked with 2 mL MEM20. Seeded constructs were placed in the incubator (37°C, 5% CO 2 , 95% humidity) and fed with fresh media 3 times a week for 9 days. Cells were then grown an additional 5 days without changing media; at the end of this time, the experiments were terminated, conditioned media collected, and assessed for cytokine production as described below.
Cytokine Detection and Measurement
Conditioned media from 3-dimensional culture was collected and stored at Ϫ70°C until assayed for cytokine production using the Human Protein Cytokine Antibody Array I kit (RayBiotech; Norcross, GA). Membranes, which contain human cytokine antibodies in duplicate, were blocked with the kit blocking buffer for 30 minutes at room temperature RT. Membranes were incubated with 1 mL of conditioned media for 105 minutes at RT. Membranes were rinsed with the kit buffer, incubated with 1 mL of biotin-conjugated antibody for 105 minutes at RT, washed, and incubated with 2 mL of HRPconjugated streptavidin at 4°C for 19 hours. Signals were detected using a chemiluminescence imaging system (LAS 3000; Fujifilm Medical Systems USA, Inc., Stamford, CT). Replicate cytokine relative intensity values were averaged and normalized to controls assayed on the same membrane. The cytokine assays were also preformed on 3 aliquots of MEM20 and background adjusted from test samples if required. (A high background was encountered in the TGF-␤ cytokine analysis with this system which precluded analysis of that cytokine.)
Cell Proliferation Assays
Cell proliferation was evaluated by seeding intervertebral disc cells in monolayer in tissue culture plates at known cell densities. The cells were allowed to adhere to the plates and then treated with experimental media as described above. After 6 days of culture, the wells were rinsed, and held at Ϫ80°C. The FluoReporter Blue Fluorometric dsDNA Quantitation kit (Molecular Probes, Inc.; Eugene, OR) was used to label the dsDNA in the cells. Fluorescence was measured using the Cytofluor Multiwell Plate Reader Series 4000 (Applied Biosystems, Boston, MA), which measured the signal from the FluoReporter Blue dye using an excitation of 360/40 and an emission of 460/40 with the gain set to 62 to eliminate background fluorescence. The fluorescence of the experimental groups was compared with that of a series of previously prepared standards to determine cell number. Tests were run in duplicate for each anulus culture, and results averaged for statistical analysis.
Assay of Total Sulfated Glycosaminoglycan Production
A paired experimental design was used to determine PG production in control or 1,25(OH) 2 D 3 -treated cells, or in control or 24,25-D 3 -treated cells using the dimethylmethylene blue assay.
Lumbar anulus cells were tested in 3-dimensional culture in a collagen sponge for 14 days in the presence or absence of 1,25(OH) 2 D 3 as described above. Glycosaminoglycan determination: The 1,9 dimethylmethylene blue (DMB) assay was used to assess S-GAG production with modifications of the previously described method. 29, 30 DMB (Aldrich, Milwaukee, WI) solution was prepared and stored at room temperature in an amber bottle. Collagen sponge constructs containing cells were rinsed 3 times in Hanks Balanced Salt Solution, HBSS (Gibco, Carlsbad, CA). Replicates were combined in 1.5 mL microcentrifuge tubes and collagenase type V (Sigma) in HBSS (Gibco) was added to produce a final concentration of 1.0 units/mL. The microcentrifuge tubes were incubated at 37°C until the sponge was completely digested (15-30 minutes). Samples were assayed in duplicate by mixing 0.1 mL of sample with 1.25 mL DMB solution. For standards, 0 to 7.5 g chondroitin sulfate (Sigma, St. Louis, MO) was added to 1.25 mL DMB solution. All tubes were incubated at room temperature in the dark for 30 minutes followed by centrifugation at room temperature for 15 minutes at 10,000 rpm. One milliliter of the supernatant was removed and the absorbency read at 595 nm using a Beckman DU 600 spectrophotometer (Fullerton, CA). Formate buffer, pH 3.1, was used as a blank. Sample concentrations were determined from the standard curve and results expressed as g S-GAG/mL.
Statistical Methods
Statistical analysis used standard methods employing SAS software (version 8.2, SAS Institute, Cary, NC), and GraphPad InStat, version 3.06 (San Diego, CA). A P value of 0.05 was considered statistically significant. Analyses performed included t tests, paired t tests and analysis of variance.
Results
Aims of the present work were to determine if we could identify expression of the VDR in vivo and in vitro in anulus cells, and to test the effect of in vitro exposure to 1,25(OH) 2 D 3 and 24,25-D 3 on anulus cell proteoglycan and cytokine production in 3-dimensional culture.
Human Anulus Cells Express the VDR In Vivo and In Vitro
Immunolocalization studies were performed using human disc tissue from both young and adult subjects (Table 1). In young subjects, the outer anulus showed positive VDR cytoplasmic localization in all anulus cells ( Figure 1A ). In the inner anulus of young subjects, however, some cells were present that were negative for expression of the VDR ( Figure 1B, arrows) .
In adult subjects in regions of healthy lamellar anulus, spindle-shaped anulus cells were present with both positive and negative localization of the VDR (Figure 2A ). Cells encapsulated in layers of matrix material ( Figure  2B) , and cells present in clusters (Figure 2C ), also were positive for VDR localization; there were, however, occasional cells that were negative for localization ( Figure  2, arrows) .
Cultured human anulus cells were also assessed for localization of the VDR receptor. Anulus cells cultured in monolayer showed uniform positive localization (Figure 3A) . Cells were also cultured in agarose, a 3-dimensional microenvironment, which more closely mimics the disc in vivo than does the monolayer methodology. Three-dimensional-cultured cells also showed positive localization of the VRD ( Figure 3C ).
1,25(OH) 2 D 3 Exposure In Vitro Does Not Alter Proteoglycan Production but Reduces Cell Proliferation
We next investigated the effect of 10 Ϫ8 M 1,25-(OH) 2 D 3 on cell proliferation in monolayer culture and on glycosaminoglycan production in 3-dimensional culture. (Initial pilot studies of anulus cells in 3-dimensional culture tested doses of 10 Ϫ8 M, 10 Ϫ7 M, and 10
Ϫ6
, and resulted in the choice of 10 Ϫ8 M 1,25-(OH) 2 D 3 in studies performed here; data not shown). 10 Ϫ8 M 1,25(OH) 2 D 3 exposure for a 6-day exposure resulted in proliferation levels significantly lower than control levels (under standard 20% FBS culture conditions) (Figure 4) .
The vitamin D metabolite 24,25(OH) 2 D 3 (abbreviated here as 24,25-D 3 ) was also included in these studies at a concentration of 10 Ϫ7 M for assessment of effects on proteoglycan production; 1,25(OH) 2 D 3 was used at a concentration of 10 Ϫ8 M. Abundant proteoglycan-containing extracellular matrix was identified in histologic preparations of both control and 1,25(OH) 2 D 3 -treated cells (Figures 5A and B) . As shown in Figure 5C , exposure to 1,25(OH) 2 D 3 did not significantly alter proteoglycan production compared with controls. Similar findings were seen with 24,25-D 3 -treatment as shown in Table 3 .
Influence of 1,25(OH) 2 D 3 or 24,25-D 3 Exposure on Cytokine Production in 3-Dimensional Culture
In order to more closely mimic the in vivo microenvironment, production of cytokines by cells exposed to 1,25(OH) 2 D 3 in vitro was assessed using cells established in 3-dimensional collagen sponge culture. Use of a cytokine array analysis methodology enabled us to assay Table 1 , aged 20 years, ϫ250; B, Subject #13, Table 1 , aged 39 years, ϫ350; C, Subject #12 Table 1, aged 41 years, ϫ280; D, adjacent section to C, processed as a negative control; ϫ330). 
Discussion
Intragenic polymorphisms in the VDR gene have recently been shown to be associated with disc degeneration. 16 -18 1,25(OH) 2 D 3 functions through its VDR and can have important physiologic effects on a variety of cells and tissues. Despite these two important facts, the effects of 1,25(OH) 2 D 3 on human disc cells appear to be unexplored to date. The objective of the present study was to determine whether the vitamin D receptor (VDR) is expressed by anulus cells of the human disc, and, if so to then examine the effect of 1,25(OH) 2 D 3 on anulus cell proliferation and on production of cytokines during 3-dimensional culture.
The specimens examined here with immunocytochemistry showed that outer anulus cells showed uniform presence of the VDR in discs from young donors. In adult disc specimens from surgery or from control donors, some negative cells were present in addition to those showing positive VDR localization. Work is currently going on in our laboratory to determine whether such cells might be undergoing senescence or might represent cells in different stages of differentiation.
Effects of 1,25-(OH) 2 D 3 on Cell Proliferation
Anulus cells exposed to 10 Ϫ8 M 1,25-(OH) 2 D 3 in vitro showed a significantly lowered proliferation compared with control cells fed MEM with 20% FBS (Figure 4) . Considerable literature using various cell types, including chondrocytes and cancer cells, supports the finding that 1,25-(OH) 2 D 3 has an antiproliferative effect. 4 19 Repeated measures analysis of variance showed P ϭ 0.014. also has a recognized role in cartilage differentiation and maturation during the process of bone formation at the physis, and chondrocytes can respond differently to 1,25-(OH) 2 D 3 and to 24,25-(OH) 2 D 3 depending on their stage of maturation. 37 In the present work, anulus cell treatment with 1,25-(OH) 2 D 3 and to 24,25-(OH) 2 D 3 did not result in increased proteoglycan production based on our DMB assay findings. In a previous chondrocyte cell line study, Akiyama et al found similar results with 1,25-(OH) 2 D 3 treatment. 38 In our study, the lack of proteoglycan synthesis may have been related potentially lower cells numbers in 3-dimensional cultures treated with 1,25-(OH) 2 D 3 . Alternatively, the lack of effect on proteoglycan production may have been related to the doses of 1,25-(OH) 2 D 3 and to 24,25-(OH) 2 D 3 employed here.
1,25-(OH) 2 D 3 has recently been found to modulate the expression of chemokines and cytokines in pancreatic islets in work by Gysemans et al. 39 In vivo and in vitro treatment with 1,25-(OH) 2 D 3 decreased the cytokine-induced expression of IL-1␤, IL-15, and the chemokine IP-10.
In the present work, 1,25(OH) 2 D 3 -treated cells showed significantly decreased production of vascular endothelial growth factor (VEGF) (P ϭ 0.01), monocyte chemoattractant protein-1 (MCP-1) (P ϭ 0.0006), angiogenin (P ϭ 0.002), and thrombopoietin (P ϭ 0.03) compared with paired controls. 24,25-D 3 -treated cells showed significantly elevated VEGF-D (P ϭ 0.01), ␤-fibroblast growth factor (0.03), and significantly decreased interleukin-8, interferon-␥, leptin, MCP-1, and TIMP-2 (tissue inhibitor of metalloproteinases-2) compared with paired controls (P Յ 0.01). We now know that cytokines can be involved with the pathogenesis of disc degeneration. Specific interest has focused on TNF-␣ and IL-1 40 and both cytokines have been shown to increase with disc degeneration. TNF-␣ is recognized to play a role with many of the cytokines found to be expressed and significantly altered by 1,25(OH) 2 D 3 -treated cells studied here. Thus it may be possible that there is an in vivo action of 1,25(OH) 2 D 3 associated with TNF-␣. Future studies are needed to explore this hypothesis. Specific rela- tionships of the cytokines identified here and the disc are described below.
MCP-1, IL-8, and bFGF. Both MCP-1 and IL-8 have previously been reported to be present in herniated disc tissue. There is a considerable body of research on MCP-1, a potent macrophage chemoattractant, which is produced after stimulation with tumor necrosis factor-alpha (TNF-␣) and IL-1␤ in experimental models, [41] [42] [43] [44] and which has also been studied in human disc herniated tissue. 42, [45] [46] [47] Burke et al have reported that both MCP-1 and IL-8 are present in both control and herniated disc specimens. 45, 48 Burke et al have also shown the human nucleus pulposus response to a pro-inflammatory stimulus by production of inflammatory mediators, including IL-6, LI-8, and bFGF. bFGF has also been studied by Nagano et al 49 and by Tolonen et al 50 in the disc. There continues to be both research and clinical interest in the role of MCP-1 in the resorption of herniated disc tissue, and in the role of inflammatory mediators in low back pain.
VEGF, VEGF-D Angiogenin. VEGF and angiogenin are potent angiogenic factors, and VEGF-D is a potent angiogenic mediator because it recognizes and activates vasculature. VEGF can be induced by agents produced in the disc such as IL-1. Current studies have shown that VEGF-D can be produced by several cell types, including osteoblasts. 51 Kato et al, 52 Haro et al, 53 and Tolonen et al 54 have all contributed to our understanding of the expression of VEGF in the disc. Hara et al postulated that VEGF may be implicated in the neo-vascularization of herniated disc tissue. 53 Data also indicate that TNF-␣ can upregulate the expression of VEGF in experimental culture systems.
53
Thrombopoietin. Thrombopoietin is a colony stimulating factor first recognized for its role in platelet production. However, it is now viewed as a hormone with a function in cell survival. 55 Our work here appears to be the first showing an association with human anulus cells.
IFN-␥.
Park et al have previously shown production of IFN-␥ by human disc tissue. 56 This study showed that concentrations of IFN-␥ were greater in herniated than in nonherniated discs. This study also showed that a negative correlation was identified between the levels of IFN-␥ and IL-4 expression.
Leptin. Leptin acts not only as a metabolic signal related to energy homeostasis, but also as an endocrine hormone regulating traditional endocrine systems and neuroendocrine function in various cells. It participates in bone remodeling and acts as a growth factor stimulating proliferation. Recent work from our laboratory has documented the presence of leptin and leptin receptors in the human anulus. 57 Interest remains high regarding the mitogenic role of leptin in the disc.
TIMP-2. Production of tissue inhibitor of matrix metalloproteinase-2 by 3-dimensional-cultured anulus cells was significantly decreased with 24,25-D 3 -treatment. The matrix metalloproteinases (MMPs) are involved in degradation of the extracellular matrix, and in healthy matrix this activity is counterbalanced by the activity of the TIMPs. MMP-2 is a gelatinase, and TIMP-2 acts as its anticatabolic agent. The presence of both MMP-2 and TIMP-2 are well recognized in disc. 20, 58 Because of their anticatabolic activity, the TIMPs have attracted interest as a potential molecule important for biologic disc therapy. 59 
Limitations of the Present Study
The present work has several shortcomings that merit attention. Potential confirmatory future work should assess outer and inner anulus cells, and cells from the nucleus pulposus, and include a dose-response study for both 1,25(OH) 2 D 3 and 24,25-D 3 treatments, and should include cell count of DNA determinations. Although healthy disc tissue is difficult to obtain, larger cell studies should include a greater number of healthier, Thompson Grade II cells, and also a greater number of more degenerate Thompson Grade V cells. There is also a need to further study the VDR in disc cells, looking for cytoplasmic versus nuclear localization. Since the VDR is present in more than 30 different tissues, it is important to further define its role in disc cell biology. As noted recently by Wu-Wong and Melnick, 60 the VDR can function in regulation of several pathways as an endocrine, paracrine and/or autocrine factor, and various VDRactivators can have differing effects on the endocrine versus the paracrine/autocrine actions.
Conclusion
Although several studies have found relationships between intragenic polymorphisms in the VDR gene and disc degeneration, 16 -18 it is somewhat surprising that there have been no studies to date investigating the effect of the active metabolite of vitamin D, 1,25-(OH) 2 
Key Points
• Although intragenic polymorphisms in the vitamin D receptor gene have been associated with disc degeneration, the effect of 1,25(OH) 2 D 3 on human disc cells is unexplored.
• In this study, anulus cells were shown to express the vitamin D receptor in vivo and in vitro.
• Exposure to 1,25(OH) 2 D 3 significantly reduced cell proliferation in vitro (P ϭ 0.03), but proteoglycan production in 3-dimensional culture was unchanged.
• 1,25(OH) 2 D 3 -treated cells in 3-dimensional showed significantly decreased production of vascular endothelial growth factor (VEGF), monocyte chemoattractant protein-1 (MCP-1), angiogenin, and thrombopoietin compared with paired controls. 24,25-D 3 -treated cells showed significantly elevated VEGF-D and ␤-fibroblast growth factor, but significantly decreased interleukin-8, interferon-␥, leptin, MCP-1 and tissue inhibitor of metalloproteinases-2 compared with paired controls.
• Data suggest that 1,25(OH) 2 D 3 and 24,25-D 3 may play roles as regulators of cell proliferation and production of specific cytokines in the lumbar anulus.
